Zynova Tech Launches the Title Industry’s First Automated Workshare Platform for Compliant, Multi-Jurisdictional Order Flow 
Masar Destination Achieves LEED for Communities Gold Certification 
Sir Ivan Releases “Love Is The Piece” Medexus to Participate in Two Upcoming Virtual Investor Conferences
TORONTO and CHICAGO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”)…
Lyell Immunopharma Announces Return of Dr. Rick Klausner as Board Chair
SOUTH SAN FRANCISCO, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Lyell), (Nasdaq:…
Enzo Biochem to Report First Quarter 2022 Financial Results and Business Update on Wednesday, December 15th
Conference Call and Webcast Scheduled for December 15, 2021, 4:30 pm ET NEW YORK, NY,…
Context Therapeutics® Reports Third Quarter 2021 Operating and Financial Results
Entered into $31.25 million Private Placement Agreement Completed Initial Public Offering of Common Stock and…
Ultimovacs Granted Orphan Drug Designation by FDA for UV1 Cancer Vaccine in Metastatic Melanoma
Designation covers UV1 in Metastatic Melanoma as sole agent or part of combination Seven-year market…
Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on its COVID-19 Vaccine Program VLA2001
Saint-Herblain (France), December 2, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
Ultimovacs ASA: Mandatory notification of trade by primary insider
Oslo, 2 December 2021, Carlos de Sousa, Chief Executive Officer and primary insider in Ultimovacs…
Pan-Biome Pharmaceuticals, Inc. provides update on its longevity research program: its compounds modulate inflammation, the gut microbiome, and increase lifespan of C. elegans by 30%
VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) — Pan-Biome Pharmaceuticals, Inc., a Vancouver based…
PHBI – Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset
Carson City, Nevada, Dec. 02, 2021 (GLOBE NEWSWIRE) — Pharmagreen Biotech, Inc., (OTC Pink: PHBI),…
Rapid Therapeutic Science Laboratories to Present at the Benzinga Global Small Cap Conference
DALLAS, Dec. 02, 2021 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories (OTC: RTSL) (“Rapid Therapeutic”…
Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Bespoke Extracts to Acquire Colorado Based Wonderleaf, LLC
Transaction provides Bespoke with a licensed marijuana infused production facility in Colorado. DENVER, Colorado., Dec….
Rubius Therapeutics Named to the List of Top Places to Work in Massachusetts by the Boston Globe and Top 3 Best Places to Work in Rhode Island by Providence Business News
Company Earns Spot on Both Lists for Second Year in a Row CAMBRIDGE, Mass., Dec….
Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery
EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq:…
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances in Utilizing CRISPR Genome Editing to Increase Seed Oil Content in Camelina at Canola Week Conference
WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
Albireo Expands Leadership with Constantine Chinoporos as Chief Business Officer
– New chief business officer to oversee Company’s corporate and business development strategy – BOSTON,…
Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays
78% of People Surveyed Want More Holistic Health Support This Season Manitoba Harvest. Manitoba Harvest….
ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Potential Treatment for Patients Hospitalized with COVID-19
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline readout of clinical…
Codiak’s Engineered Exosomes Promote T Cell and Antibody Responses to SARS-CoV-2 in vivo, Supporting the Potential for a Broadly Protective Pan-Beta Coronavirus and Variant Vaccine
Preclinical data at World Vaccine & Immunotherapy Congress 2021 show broad immunogenicity and neutralization against…
Mindset Pharma to Participate in Stifel GMP’s The Future of Healthcare Conference on December 8th
TORONTO, Dec. 02, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB:…